Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium

International Journal of Pharmaceutics

Volumn 350, Issue 1-2, 2008, Pages 197-204

  Ren, Shan ^a   Park, Mi Jin ^a   Sah, Hongkee ^b   Lee, Beom Jin ^a  

^a Kangwon National University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Aqueous stability; Pharmaceutical excipients; Rabeprazole; Stabilizing mechanism; Thioether rabeprazole

Indexed keywords

CETOMACROGOL; CREMOPHOR; EXCIPIENT; GELUCIRE; MACROGOL 6000; POLIDOCANOL; POLOXAMER; RABEPRAZOLE; SULFIDE;

ACCURACY; ARTICLE; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG FORMULATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; KINETICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; EXCIPIENTS; MASS SPECTROMETRY; SOLUTIONS;

EID: 38349165563     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.08.035     Document Type: Article

References (31)

1. Badawy S.I., Gawronski A.J., and Alvarez F.J. Application of sorption-desorption moisture transfer modeling to the study of chemical stability of a moisture sensitive drug product in different packaging configurations. Int. J. Pharm. 223 (2001) 1-13
2. Black J., Buechter D.D., Chinn J.W., Gard J., and Thurston D.E. Studies on the stability of vinblastine sulfate in aqueous solution. J. Pharm. Sci. 77 (1988) 630-634
3. Carswell C., and Goa K. Rabeprazole: an update of its use in acid-related disorders. Drugs 61 (2001) 2327-2356
4. Chong Y., Gumina G., Mathew J.S., Schinazi R.F., and Chu C.K. l-2′,3′-Didehydro-2′,3′-dideoxy-3′-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance. J. Med. Chem. 46 (2003) 3245-3256
5. Cirri M., Maestrelli F., Corti G., Mura P., and Valleri M. Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants. Drug Deliv. 14 (2007) 247-255
6. Costantino H.R., Carrasquillo K.G., Cordero R.A., Mumenthaler M., Hsu C.C., and Griebenow K. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone. J. Pharm. Sci. 87 (1998) 1412-1420
7. Crowley P.J. Excipients as stabilizers. Pharm. Sci. Technol. Tod. 2 (1999) 237-243
8. Di L., Kerns E.H., Chen H., and Petusky S.L. Development and application of an automated solution stability assay for drug discovery. J. Biomol. Screen 11 (2006) 40-46
9. Dinarvand R., Moghadam S.H., Sheikhi A., and Atyabi F. Effect of surfactant HLB and different formulation variables on the properties of poly-d l-lactide microspheres of naltrexone prepared by double emulsion technique. J. Microencapsul. 22 (2005) 139-151
10. Ekpe A., and Jacobsen T. Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography. Drug Dev. Ind. Pharm. 25 (1999) 1057-1065
11. Fuhr U., and Jetter A. Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. Pharmazie 57 (2002) 595-601
12. Fujioka T., Kawasaki H., Su W.W., and Nasu M. In vitro anti microbial activity against H. pylori and clinical efficacy of various drugs. Jpn. J. Clin. Med. 51 (1993) 3255-3260
13. Hancock B.C., Shamblin S.L., and Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm. Res. 12 (1995) 799-806
14. Heerklotz H., and Seelig J. Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration. Biophys. J. 78 (2000) 2435-2440
15. Kerns E.H., and Di L. Pharmaceutical profiling in drug discovery. Drug Discov. Today 8 (2003) 316-323
16. Lin S.C. Biosurfactants: recent advances. J. Chem. Technol. Biotechnol. 66 (1996) 109-120
17. Loftsson T., and Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85 (1996) 1017-1025
18. Loukas Y.L., Vraka V., and Gregoriadis G. Drugs, in cyclodextrins, in liposomes: a novel approach to the chemical stability of drugs sensitive to hydrolysis. Int. J. Pharm. 162 (1998) 137-142
19. Miura M., Tada H., Satoh S., Habuchi T., and Suzuki T. Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction. J. Pharm. Biomed. Anal. 41 (2005) 565-570
20. +-ATPase is correlated with the rate of acid-activation of the inhibitor. Biochem. Pharmacol. 39 (1990) 661-667
21. + ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography. J. Chromatogr. B 660 (1994) 211-220
22. Okubo M., Kobayashi H., Matoba T., and Oshima Y. Incorporation of nonionic emulsifiers inside particles in emulsion polymerization: mechanism and methods of suppression. Langmuir 22 (2006) 8727-8731
23. Pantoflickova D., Dorta G., Ravic M., Jornod P., and Blum A.L. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Aliment. Pharmacol. Ther. 17 (2003) 1507-1514
24. Richardson P., Hawkey C.J., and Stack W.A. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs 56 (1998) 307-335
25. Sabry S.M., Abdel-Hady M., Elsayed M., Fahmy O.T., and Maher H.M. Study of stability of methotrexate in acidic solution spectrofluorimetric determination of methotrexate in pharmaceutical preparations through acid-catalyzed degradation reaction. J. Pharm. Biomed. Anal. 32 (2003) 409-423
26. Santoro M.I., Hackmann E.R., and Borges V.M. Stability of phenobarbital sodium in liquid pharmaceutical preparations. Boll. Chim. Farm. 131 (1992) 226-229
27. Turkoglu M., Varol H., and Celikok M. Tableting and stability evaluation of enteric-coated omeprazole pellets. Eur. J. Pharm. Biopharm. 57 (2004) 279-286
28. Villalobos-Hernandez J.R., and Villafuerte-Robles L. Effect of carrier excipient and processing on stability of indorenate hydrochloride/excipient mixtures. Pharm. Dev. Technol. 6 (2001) 551-561
29. Yang P., and Macdonald F. Solution stability of factor Xa inhibitors as a function of pH. Drug Dev. Ind. Pharm. 30 (2004) 967-973
30. Zhang Y., Chen X., Gu Q., and Zhong D. Quantification of rabeprazole in human plasma by liquid chromatography-tandem mass spectrometry. Anal. Chim. Acta 523 (2004) 171-175
31. Zhong X.F., Varshney S.K., and Eisenberg A. Critical micelle lengths for ionic blocks in solutions of polystyrene-b-poly (sodium acrylate) ionomers. Macromolecules 25 (1992) 7160-7167